Gene Deregulation in Cortical Dementia
皮质痴呆的基因失调
基本信息
- 批准号:10191132
- 负责人:
- 金额:$ 353.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Frontotemporal dementia (FTD) is a common aging-related neurodegenerative disease and shares a wide
spectrum of clinical, pathological, and genetic features with amyotrophic lateral sclerosis (ALS). Recent advance
in genetics study indicates that pathogenic mutations of most ALS genes are also causative to FTD. Substantial
evidence from genetics study suggests Ubqln2 as a causative gene of both ALS and FTD, but how Ubqln2
causes the diseases is not known. Overexpression of Ubqln2 with or without a pathogenic mutation causes
indistinguishable phenotypes reminiscent of ALS and FTD, suggesting that pathogenic mutation or excess
expression of Ubqln2 is both pathogenic for the diseases. As deletion of the Ubqln2 in knockout rodents does
not affect neuronal function, pathogenic Ubqln2 likely causes the diseases through a gain of unknown function.
A prominent feature of Ubqln2 related diseases is protein aggregation, which is well reproduced in transgenic
rodents overexpressing Ubqln2. Using biochemical approaches, we attempt to unravel how pathogenic Ubqln2
induces neuronal dysfunction via its gained aggregation-prone feature. Our preliminary studies observed that
Ubqln2 is deregulated in FTD patients and at miRNA deficiency. The proposed research will determine how
deregulated Ubqln2 expression is related to impaired cognitive function and neuronal death in novel rat models
and how miRNA deficiency leads to deregulated Ubqln2 expression and to cortical dementia in the diseases.
Upon completion, the proposed research will gain a mechanistic insight on Ubqln2 related diseases and likely
will identify a network of genes essential to neuronal survival and cognitive function.
额颞叶痴呆(Frontotemporal dementia,FTD)是一种常见的与衰老相关的神经退行性疾病,
肌萎缩侧索硬化症(ALS)的临床、病理和遗传特征谱。研究进展
遗传学研究表明,大多数ALS基因的致病性突变也是FTD的病因。实质性
来自遗传学研究的证据表明Ubqln2是ALS和FTD的致病基因,但Ubqln2如何
引起疾病的原因尚不清楚。Ubqln2的过表达(有或没有致病性突变)会导致
难以区分的表型使人联想到ALS和FTD,这表明致病性突变或过量
Ubqln 2的表达对于这些疾病都是致病的。由于敲除啮齿动物中Ubqln 2的缺失
致病性Ubqln 2可能通过获得未知的功能而引起疾病。
Ubqln2相关疾病的一个突出特征是蛋白质聚集,其在转基因小鼠中很好地再现。
过表达Ubqln 2的啮齿类动物。使用生物化学方法,我们试图解开致病性Ubqln 2
通过其获得的聚集倾向特征诱导神经元功能障碍。我们的初步研究发现,
Ubqln2在FTD患者和miRNA缺乏时失调。这项研究将确定如何
Ubqln2表达失调与新型大鼠模型中认知功能受损和神经元死亡相关
以及miRNA缺陷如何导致Ubqln2表达失调和疾病中的皮质痴呆。
完成后,拟议的研究将获得对Ubqln 2相关疾病的机制见解,
将确定神经元存活和认知功能所必需的基因网络。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
PIH1D3-knockout rats exhibit full ciliopathy features and dysfunctional pre-assembly and loading of dynein arms in motile cilia.
- DOI:10.3389/fcell.2023.1282787
- 发表时间:2023
- 期刊:
- 影响因子:5.5
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
xugang xia其他文献
xugang xia的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('xugang xia', 18)}}的其他基金
TMEM230 and Neurodegeneration in Parkinson's Disease
TMEM230 与帕金森病的神经退行性变
- 批准号:
10705592 - 财政年份:2020
- 资助金额:
$ 353.16万 - 项目类别:
TMEM230 and Neurodegeneration in Parkinson's Disease
TMEM230 与帕金森病的神经退行性变
- 批准号:
9974760 - 财政年份:2020
- 资助金额:
$ 353.16万 - 项目类别:
TMEM230 and Neurodegeneration in Parkinson's Disease
TMEM230 与帕金森病的神经退行性变
- 批准号:
10268170 - 财政年份:2020
- 资助金额:
$ 353.16万 - 项目类别:
TMEM230 and Neurodegeneration in Parkinson's Disease
TMEM230 与帕金森病的神经退行性变
- 批准号:
10459555 - 财政年份:2020
- 资助金额:
$ 353.16万 - 项目类别:
Study on PFN1 Pathobiology Using Rat Models
利用大鼠模型进行 PFN1 病理学研究
- 批准号:
10376166 - 财政年份:2019
- 资助金额:
$ 353.16万 - 项目类别:
Study on PFN1 Pathobiology Using Rat Models
利用大鼠模型进行 PFN1 病理学研究
- 批准号:
9912205 - 财政年份:2019
- 资助金额:
$ 353.16万 - 项目类别:
Study on PFN1 Pathobiology Using Rat Models
利用大鼠模型进行 PFN1 病理学研究
- 批准号:
10189826 - 财政年份:2019
- 资助金额:
$ 353.16万 - 项目类别:
Study on PFN1 Pathobiology Using Rat Models
利用大鼠模型进行 PFN1 病理学研究
- 批准号:
10604337 - 财政年份:2019
- 资助金额:
$ 353.16万 - 项目类别:
相似海外基金
RBFOX2 deregulation promotes pancreatic cancer progression through alternative splicing
RBFOX2 失调通过选择性剪接促进胰腺癌进展
- 批准号:
10638347 - 财政年份:2023
- 资助金额:
$ 353.16万 - 项目类别:
Role of mTOR in Circadian and Sleep Deregulation in Smith-Kingsmore Syndrome (SKS)
mTOR 在史密斯-金斯莫尔综合征 (SKS) 昼夜节律和睡眠失调中的作用
- 批准号:
10586191 - 财政年份:2023
- 资助金额:
$ 353.16万 - 项目类别:
Doctoral Dissertation Research in Economics: The Effect of Deregulation on the Cost, Availability, and Quality of Health Care
经济学博士论文研究:放松管制对医疗保健成本、可用性和质量的影响
- 批准号:
2242324 - 财政年份:2023
- 资助金额:
$ 353.16万 - 项目类别:
Standard Grant
Epigenome Deregulation by De Novo H3.3 Histone Mutations Linked to Neurodegeneration.
De Novo H3.3 组蛋白突变导致的表观基因组失调与神经退行性变相关。
- 批准号:
479088 - 财政年份:2023
- 资助金额:
$ 353.16万 - 项目类别:
Operating Grants
Impact of early life systemic metabolic deregulation on reprogramming of CNS microglia in retinal vascular disease
生命早期全身代谢失调对视网膜血管疾病中枢神经系统小胶质细胞重编程的影响
- 批准号:
461826 - 财政年份:2022
- 资助金额:
$ 353.16万 - 项目类别:
Operating Grants
In utero exposure to alcohol-induced mammary stem cell deregulation and tumor risk later in life.
在子宫内暴露于酒精会导致乳腺干细胞失调和日后患肿瘤的风险。
- 批准号:
10618844 - 财政年份:2022
- 资助金额:
$ 353.16万 - 项目类别:
Deregulation of long noncoding RNAs in cancer
癌症中长非编码RNA的失调
- 批准号:
10674961 - 财政年份:2022
- 资助金额:
$ 353.16万 - 项目类别:
Deregulation of Sleep/Wake Homeostasis by Binge Alcohol Use Following Traumatic Brain Injury
创伤性脑损伤后酗酒导致睡眠/觉醒稳态失调
- 批准号:
10683216 - 财政年份:2022
- 资助金额:
$ 353.16万 - 项目类别:
Deregulation of Sleep/Wake Homeostasis by Binge Alcohol Use Following Traumatic Brain Injury
创伤性脑损伤后酗酒导致睡眠/觉醒稳态失调
- 批准号:
10527774 - 财政年份:2022
- 资助金额:
$ 353.16万 - 项目类别: